SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-04-004403
Filing Date
2004-11-19
Accepted
2004-11-19 17:28:15
Documents
3
Period of Report
2004-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w69039e8vk.htm 8-K 20096
2 EXHIBIT 10.01 w69039exv10w01.txt EX-10.01 129621
3 EXHIBIT 10.02 w69039exv10w02.txt EX-10.02 29066
  Complete submission text file 0000950133-04-004403.txt   180656
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23736 | Film No.: 041158832
SIC: 2834 Pharmaceutical Preparations